Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| MEIRAGTX | 12 | - | -17,28 % | ||
| BIONTECH | 3 | 13 | +2,91 % | ||
| ALKERMES | 3 | 8 | -0,64 % | ||
| ALLOGENE THERAPEUTICS | 3 | 6 | +9,24 % | ||
| SPYRE THERAPEUTICS | 3 | 3 | +1,71 % | ||
| INSMED | 2 | 7 | -2,29 % | ||
| GILEAD SCIENCES | 2 | 5 | -1,01 % | ||
| ETON PHARMACEUTICALS | 2 | 5 | -9,46 % | ||
| VIR BIOTECHNOLOGY | 2 | 2 | -1,15 % | ||
| ACLARIS THERAPEUTICS | 2 | 1 | +0,18 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01:30 | BEONE MEDICINES (06160): DIRECTOR NOMINEES AND PROPOSED CHANGES IN BOARD COMMITTEE COMPOSITION | 1 | HKEx | ||
| Do | Altimmune-Aktionäre stimmen Verdopplung des genehmigten Aktienkapitals zu | 3 | Investing.com Deutsch | ||
| Do | Stifel initiates Definium stock with buy rating on anxiety drug | 3 | Investing.com | ||
| Do | Spyre Therapeutics closes $463.5M stock offering | 1 | Investing.com | ||
| Do | Autolus Therapeutics bestellt neuen Abschlussprüfer für das Geschäftsjahr 2026 | 4 | Investing.com Deutsch | ||
| Do | Spyre Therapeutics schließt Kapitalerhöhung über 463,5 Mio. US-Dollar ab | 2 | Investing.com Deutsch | ||
| Do | Is Vertex Pharmaceuticals' Empire in Trouble? | 5 | The Motley Fool | ||
| Do | Allogene raises $200.4 million in stock offering | 1 | Investing.com | ||
| Do | Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million | 1 | GlobeNewswire (USA) | ||
| Do | Janux doses first patient in JANX014 prostate cancer trial | 1 | Investing.com | ||
| Do | Trevi Therapeutics launches $150M public stock offering | 4 | Seeking Alpha | ||
| Do | Protagonist Therapeutics Reports Granting of Inducement Awards | 203 | ACCESS Newswire | NEWARK, CA / ACCESS Newswire / April 16, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on April 15, 2026, it issued inducement awards to two recently hired employees in accordance... ► Artikel lesen | |
| Do | PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 | 3 | GlobeNewswire (USA) | ||
| Do | Trevi Therapeutics, Inc.: Trevi Therapeutics Announces Proposed Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| Do | Altimmune, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Do | EyePoint, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Do | Allogene Therapeutics, Inc.: Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| Do | BAG schafft volle Transparenz: Moderna und Novavax: Bund zahlte eine Milliarde für Impfstoffe | 16 | Schweizer Fernsehen | ||
| Do | Viatris, Teva kick off separate recalls over dissolution, raw material issues | 10 | FiercePharma | ||
| Do | Autolus Therapeutics plc - 8-K, Current Report | 1 | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.